Skip to main content
رجوع
Watch Compare

AXIM BIOTECHNOLOGIES, INC.

جودة البيانات: 100%
AXIM
OTC Manufacturing Chemicals
KWD 0.01
KWD 0.00 (0.00%)
القيمة السوقية: 1.93 M
السعر
KWD 0.01
القيمة السوقية
1.93 M
نطاق اليوم
KWD 0.01 — KWD 0.01
نطاق 52 أسبوعًا
KWD 0.00 — KWD 0.03
حجم التداول
223,916
فتح KWD 0.01
متوسط 50 يوم / 200 يوم
KWD 0.01
44.95% below
متوسط 50 يوم / 200 يوم
KWD 0.01
36.84% below

Quick Summary

النقاط الرئيسية

Revenue declined -52.85% annually over 5 years
Negative free cash flow of -752,995.0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 398.12%
Capital efficient — spends only 3.40% of revenue on capex

النمو

Revenue Growth (5Y)
-52.85%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)345.27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-4452.06%
Op. Margin-2490.35%

الأمان

Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-5.62

التقييم

PE (TTM)
-0.47
أعلى من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.5 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % -4452.1 -41.5
Rev Growth 5Y % -52.9 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 345.27% Revenue Growth (3Y) -19.15%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -52.85% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 92,898.0 Net Income (TTM) -4.14 M
ROE N/A ROA -107.95%
Gross Margin N/A Operating Margin -2490.35%
Net Margin -4452.06% Free Cash Flow (TTM) -752,995.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.00
Interest Coverage -5.62 Asset Turnover 0.02
Working Capital -6.55 M Tangible Book Value -9.53 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.47 Forward P/E N/A
P/B Ratio N/A P/S Ratio 20.79
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -38.99%
Market Cap 1.93 M Enterprise Value 7.90 M
Per Share
EPS (Diluted TTM) -0.02 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) -200.00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3.40% FCF Conversion 18.21%
SBC-Adj. FCF -914,458 Growth Momentum 398.12

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 39,518.0 8,875.0 60,460.0 0.0 799,483.0
Net Income -8.06 M -6.24 M -16.03 M -6.41 M -6.45 M
EPS (Diluted) -0.04 0.04 -0.12 -0.06 —
Gross Profit — — — 0.0 223,789.0
Operating Income -2.75 M -4.65 M -13.97 M -4.95 M -6.51 M
EBITDA — — — — —
R&D Expenses 125,496.0 153,697.0 284,869.0 426,708.0 2.45 M
SG&A Expenses 2.24 M 4.08 M — — —
D&A 427,019.0 426,126.0 2.12 M — —
Interest Expense 140,000.0 140,000.0 247,792.0 234,754.0 248,636.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 4.12 M 4.21 M 5.32 M 11.31 M 1.69 M
Total Liabilities 11.78 M 9.04 M 7.66 M 9.75 M 8.45 M
Shareholders' Equity -7.66 M -4.83 M -2.34 M 1.57 M -6.76 M
Total Debt — — 180.0 180.0 5,000.0
Cash & Equivalents — 47,282.0 452,963.0 457,181.0 511,630.0
Current Assets 156,457.0 103,979.0 636,613.0 713,104.0 1.64 M
Current Liabilities 5.98 M 3.39 M 2.58 M 1.50 M 3.40 M